Elanco Animal Health (ELAN) Cost of Revenue (2017 - 2026)

Elanco Animal Health has disclosed Cost of Revenue across 10 years of filings, most recently posting $570.0 million for Q2 2026.

• In Q2 2026, Cost of Revenue rose 7.95% year-over-year to $570.0 million; the TTM figure through Jun 2026 stood at $2.2 billion (up 10.39% YoY), while the FY2025 annual figure was $2.1 billion, up 5.94% from the prior year.
• Cost of Revenue came in at $570.0 million for Q2 2026 at Elanco Animal Health, down from $586.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $586.0 million in Q1 2026 to a low of $434.0 million in Q2 2023.
• Average Cost of Revenue over 5 years is $506.9 million, with a median of $505.0 million recorded in 2022.
• Year-over-year, Cost of Revenue fell 12.16% in 2022 and climbed 15.18% in 2023.
• Over 5 years, Cost of Revenue stood at $448.0 million in 2022, then rose by 15.18% to $516.0 million in 2023, then slipped by 2.91% to $501.0 million in 2024, then climbed by 10.78% to $555.0 million in 2025, then advanced by 2.7% to $570.0 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $570.0 million in Q2 2026, $586.0 million in Q1 2026, and $555.0 million in Q4 2025.